Cryptosporidiosis is a diarrheal disease caused by microscopic parasites named “Cryptosporidium” that can live in intestine of humans and animals. These parasites are passed through the stool of an infected animal or person. Both the parasite and disease are usually called “Crypto”. Outer shell of the parasite offers protection and allows it to persist outside the body for a long time. This outer layer also makes it resilient to chlorine-based disinfectants. In the past few years, Crypto has become the most common cause of water borne diseases which includes both drinking and recreational water. The parasite is found in every region of the world. Currently, several species of Cryptosporidium exist that have the ability to infect wide range of animals and humans. Cryptosporidium parvum and Cryptosporidium hominis are the most prevalent species of Cryptosporidium that cause disease in humans. However, infections caused by other species such as C. muris C. meleagridis, C. felis, and C. canis have also been reported across the globe.

The global cryptosporidium diagnostic testing market is projected to grow at a rapid pace in the next few years. The cryptosporidium diagnostic testing market is anticipated to be driven by increase in infections caused by water borne diseases, mandatory laws by government to check water quality and purity, and rise in importance of water testing activities in many verticals of the industry. Additionally, factors such as climate change which alters the quality or supply of water, rise in demand for rapid diagnostic tests, innovation in techniques to develop better diagnostic assays, increase in geriatric population, poor supply water with less water testing facilities in developing countries, and surge in initiatives by government and private bodies to spread awareness about waterborne diseases are likely to drive the global cryptosporidium diagnostic testing market. For example, countries such as Australia and New Zealand monitor the efficacy of health interventions for climate changes. Development of water treatment and other prevention measures are likely to diminish the effects of climate change on the incidence of cryptosporidiosis. Conventional water testing methods are generally labor intensive and also involve the possibility of contamination due to human error. Technological advancements such as automation & digitization are projected to drive the global cryptosporidium diagnostic testing market. However, less accuracy of some of the tests, high cost, and availability of products in specific regions are the factors anticipated to hamper the growth of the global cryptosporidium diagnostic testing market.

The global cryptosporidium diagnostic testing market can be segmented based on type of test and end-user. In terms of type of test, the global cryptosporidium diagnostic testing market can be divided into acid-staining test, stool culture, and others. Based on end-user, the global cryptosporidium diagnostic testing market can be classified into hospitals, commercial/private labs, physician offices, and public health labs.

In terms of region, the global cryptosporidium diagnostic testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to account for major shares of the global cryptosporidium diagnostic testing market due to high awareness of Cryptosporidiosis and other water related diseases, and initiatives taken by the government & regulatory bodies such as making some of the water tests compulsory in countries such as the U.S., the U.K. and Germany. Asia Pacific is expected to be one of the most lucrative & rapidly growing markets during the forecast period. Factors driving the cryptosporidium diagnostic testing market in the region are increase in geriatric population which has less immunologic response and prone to these infections, rise in per capita income, adoption of newly developed techniques and assays, and investment by key players.

Major players in the global cryptosporidium diagnostic testing market are Abbott Healthcare, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Elitech Group, DiaSorin, and Grifols, S.A.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.